SAG
PAHC icon

SageView Advisory Group’s Phibro Animal Health PAHC Stock Holding History

SageView Advisory Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.53K Buy
+41
New +$1.67K ﹤0.01% 2291

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SageView Advisory Group's PAHC Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Phibro Animal Health (PAHC) in Q4 2025: 41 shares worth $1.53K. The stake represents ﹤0.01% of the portfolio and ranks #2291 among its holdings.

227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

  • SageView Advisory Group held 41 shares of Phibro Animal Health worth $1.53K as of Q4 2025.
  • Phibro Animal Health was a new SageView Advisory Group position in Q4 2025.
  • Phibro Animal Health made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2291 holding.
  • 227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.